Trial Profile
Clinical Trials Insight: 700056839
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2010
Price :
$35
*
At a glance
- Drugs Imgatuzumab (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Roche
- 04 Jun 2010 Results will be presented at the 46th Annual Meeting of ASCO, according to a Roche media release.
- 04 Jun 2010 New trial record